tiprankstipranks
AFT Pharmaceuticals Ltd. (NZ:AFT)
:AFT
New Zealand Market
AFT
AFT Pharmaceuticals Ltd.
RESEARCH TOOLSreports
Want to see NZ:AFT full AI Analyst Report?

AFT Pharmaceuticals Ltd. (AFT) Income Statement

― Followers

AFT Pharmaceuticals Ltd. Income Statement

Last quarter (Q2 2026), AFT Pharmaceuticals Ltd.'s total revenue was $114.94M, an increase of 37.47% from the same quarter last year. In Q2, AFT Pharmaceuticals Ltd.'s net income was $3.30M. See AFT Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
$ 205.49M$ 195.41M$ 155.82M$ 129.83M$ 112.86M
Gross Profit
$ 89.19M$ 88.27M$ 72.16M$ 61.30M$ 48.50M
Operating Expenses
$ 77.49M$ 66.58M$ 55.04M$ 41.61M$ 39.76M
Depreciation and Amortization
$ 2.67M$ 2.01M$ 1.72M$ 1.04M$ 1.10M
EBITDA
$ 21.52M$ 27.72M$ 20.40M$ 21.12M$ 12.43M
Operating Income
$ 11.70M$ 24.23M$ 18.67M$ 20.08M$ 11.33M
Other Income/Expenses
$ 4.33M$ -2.22M$ -1.32M$ -1.70M$ -1.09M
Pretax Income
$ 16.03M$ 22.02M$ 15.80M$ 18.68M$ 7.89M
Net Income
$ 11.96M$ 15.61M$ 10.65M$ 19.85M$ 7.78M
Per Share Metrics
Basic EPS
$ 0.11$ 0.15$ 0.10$ 0.19$ 0.07
Diluted EPS
$ 0.11$ 0.15$ 0.10$ 0.19$ 0.07
Weighted Average Shares Outstanding
 104.87M 104.87M 104.85M 104.68M 103.30M
Weighted Average Shares Outstanding (Diluted)
 104.87M 104.87M 104.85M 104.68M 103.30M
Currency in NZD

AFT Pharmaceuticals Ltd. Earnings and Revenue History